Related Experiment Videos
Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity
Clinical & Experimental Metastasis
|April 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Different integrin-induced adhesion of highly liver metastatic and little metastatic colon carcinoma cells in an extracellular matrix].
Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2003
Cell biology and clinical implications of adhesion molecules in colorectal diseases: colorectal cancers, infections and inflammatory bowel diseases.
Clinical & experimental metastasis·2002
Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells.
Clinical & experimental metastasis·2001
Noninvasive molecular imaging signatures of histopathological growth patterns in colorectal cancer liver metastases.
Clinical & experimental metastasis·2026
Platelet-derived mitochondrial transfer in cancer metastasis: mechanisms, functional consequences, and translational opportunities.
Clinical & experimental metastasis·2026
THBS2: the key hub linking breast cancer stroma, immunity, and therapeutic response.
Clinical & experimental metastasis·2026
Radiomics for risk stratification in brain metastases: potential in melanoma brain metastases.
Clinical & experimental metastasis·2026
Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP).
Clinical & experimental metastasis·2026
Brain Network Convergence of Abnormal Gray Matter and Functional Activity of Pathological Dissociative Symptoms.
Psychiatry and clinical neurosciences·2026
SHMT2: a Metabolic and Immune Biomarker of Aggressive Lung Adenocarcinoma.
Journal of visualized experiments : JoVE·2026